TrialBritish journal of cancer2007

A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens.

C N Krasner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.